Early detection of liver disease in patients with alcohol use disorder improves long-term abstinence.

Aims Excessive alcohol consumption is a major global health concern, contributing to millions of deaths annually and a significant proportion of cirrhosis cases; however, standardized protocols for early identification of alcohol-associated liver disease are lacking. In this retrospective cohort stu...

Descripción completa

Detalles Bibliográficos
Publicado en:Alcohol & Alcoholism Vol. 59; no. 6; pp. 1 - 9
Autores principales: Orgill, Amelia, Jew, Michael H, Soltani, Maryam, Deioma, Ann, Grant, Meghan, Patton, Heather M, Hsu, Cynthia L
Formato: research tables/charts Journal Article
Publicado: Oxford University Press / USA Nov2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180861090&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 180861090
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        07350414
        FA3
      jtl: Alcohol & Alcoholism
      issn: 07350414
      maglogo: N
    pubinfo:
      dt: Nov2024
      vid: 59
      iid: 6
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        180861090
        180861090
        180861090
        10.1093/alcalc/agae074
        180861090
      ppf: 1
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Early detection of liver disease in patients with alcohol use disorder improves long-term abstinence.
      aug:
        au:
          Orgill, Amelia
          Jew, Michael H
          Soltani, Maryam
          Deioma, Ann
          Grant, Meghan
          Patton, Heather M
          Hsu, Cynthia L
        affil: Department of Medicine, VA San Diego Healthcare System , 3350 La Jolla Village Drive, San Diego, CA 92161 , United States
      sug:
        subj:
          Alcoholism Complications
          Pulmonary Fibrosis Epidemiology
          Liver Cirrhosis, Alcoholic Epidemiology
          Pulmonary Fibrosis Diagnosis
          Liver Cirrhosis, Alcoholic Diagnosis
          Alcoholism Therapy
          Pulmonary Fibrosis Risk Factors
          Liver Cirrhosis, Alcoholic Risk Factors
          Risk Assessment
          Early Diagnosis
          Alcohol Abstinence
          Outcomes (Health Care)
          Human
          Male
          Female
          Adult
          Middle Age
          Aged
          Veterans
          Retrospective Design
          Record Review
          Prospective Studies
          Descriptive Statistics
          Comparative Studies
          Substance Use Rehabilitation Programs
          Ultrasonography
          Chronic Disease
          Health Screening
          Collaboration
          Mental Health Personnel
          Mental Health Services
          Gastroenterologists
          Health Care Delivery, Integrated
          Pulmonary Fibrosis Ultrasonography
          Liver Cirrhosis, Alcoholic Ultrasonography
          California
          Alcohol Drinking
          Preventive Health Care
          Recovery
          Pulmonary Fibrosis Prognosis
          Liver Cirrhosis, Alcoholic Prognosis
          Data Analysis Software
          Fisher's Exact Test
          Kruskal-Wallis Test
          Post Hoc Analysis
          Multiple Logistic Regression
          Univariate Statistics
          Multivariate Analysis
          Odds Ratio
          Confidence Intervals
          Wilcoxon Signed Rank Test
          Alcoholism Rehabilitation
          Prevalence
          Funding Source
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Aims Excessive alcohol consumption is a major global health concern, contributing to millions of deaths annually and a significant proportion of cirrhosis cases; however, standardized protocols for early identification of alcohol-associated liver disease are lacking. In this retrospective cohort study, we aimed to understand the prevalence and risk factors associated with elevated liver stiffness measurement (LSM) in high-risk patients with alcohol use disorder (AUD) and identify variables associated with longitudinal abstinence and outcomes. Methods Veterans with severe AUD without known liver disease admitted to a 35-day residential substance use treatment program were offered liver health screening, including Fibroscan evaluation. Assessment of AUD severity and liver health outcomes were evaluated longitudinally by chart review. Results and Conclusions In a cohort of 257 veterans with severe AUD admitted to residential treatment, 185 underwent Fibroscan evaluation, and 22 were identified to have elevated LSM concerning for compensated advanced chronic liver disease. Patients with elevated LSM were more likely to remain abstinent after 1 year. About 41% of patients with LSM ≥ 10 kPa (5% of all screened patients) were confirmed to have cirrhosis on follow-up and incorporated into routine hepatology care. Screening of liver disease in high-risk populations with non-invasive imaging modalities provides an opportunity to identify patients at risk for compensated advanced chronic liver disease before decompensation. Identification of increased risk for advanced chronic liver disease may promote abstinence in patients with severe AUD. Collaboration between mental health professionals and hepatologists is critical for the integration of care for patients with AUD and liver disease.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N